Mirion Technologies Inc (MIR) News

Form 4 - Statement of changes in beneficial ownership of securities

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form ARS - Annual Report to Security Holders

Form DEF 14A - Other definitive proxy statements

Mirion to Elevate Radiopharmaceutical Production Quality with Advanced Apex-Guard Software

Apex-Guard™ Software Version 1.2 Introduces Robust Impurity Analysis for Enhanced Radioisotope Quality Mirion Technologies (NYSE: MIR), a global...

Mirion Technologies Awarded Contracts for TerraPower Natrium® Reactor Demonstration Project

Mirion selected to supply Radiation Monitoring System (RMS) and Nuclear Instrumentation System (XIS) for advanced nuclear reactor...

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Mirion to Present at the 46th Annual Raymond James Institutional Investor Conference

Mirion (NYSE: MIR) announced today that Chief Executive Officer, Thomas Logan, and Chief Financial Officer, Brian Schopfer, will present at the...

Mirion to Present at Citi’s 2025 Global Industrial Tech and Mobility Conference

Mirion (NYSE: MIR) announced today that Chief Executive Officer, Thomas Logan, and Chief Financial Officer, Brian Schopfer, will present at...